Can you explain our partnerships with LifeGen and Stanford?

New customer? Sign up today!

Ask the Expert

Can you explain our partnerships with LifeGen and Stanford?

JoeChang

A number of distributors have been asking about our partnerships with LifeGen and Stanford. Let me briefly explain what these partnerships entail and how they benefit Nu Skin.


LifeGen Partnership:

Nu Skin has signed a research, license and development agreement with LifeGen Technologies to collaborate on anti-aging research that supports the company’s product strategy to target the sources of aging. More specifically, the relationship with LifeGen adds significant fuel to Nu Skin’s scientific engine with the exclusive advantage to continue to identify youth gene clusters and develop additional proprietary methods to reset gene activity to more youthful patterns.   


Stanford Partnership:

Nu Skin has worked with Stanford University since 1999 and this latest agreement is a multi-year extension of our ongoing collaboration. Nu Skin and Stanford University will collaborate on anti-aging, developmental biology and dermatological research that supports the company’s unique anti-aging strategy to target the sources of aging. More specifically, the relationship with Stanford gives Nu Skin scientists the opportunity to collaborate with notable and highly credentialed scientists for basic and applied research on innovative insights into why and how skin ages, translate these insights from basic science into human application and provide additional opportunities to publish and present scientific papers.


About LifeGen:            

LifeGen was co-founded in November 2000 by Drs. Richard Weindruch and Tomas A. Prolla, professors at the University of Wisconsin-Madison and leaders in the fields of gerontology and genetics. The mission of LifeGen Technologies is to discover the genetic basis of the aging process with the goal of increasing a healthy life span. LifeGen's pioneering research has resulted in several pending patents, and on-going research is expected to yield additional, important intellectual property. Additionally, LifeGen has a patent application for the use of such "gene expression profiling" as a method to measure the progression of the aging process at the molecular level in individual organs.


About Stanford:

Stanford University School of Medicine is currently ranked sixth in research, according to U.S. News and World Report. The school consistently ranks among the top 10 U.S. medical schools, integrating research, medical education, patient care and community service.

Divider